GR
Galera Therapeutics, Inc.
GRTX · OTC
$17.15 +9.80% (+$1.53)
Market Cap $3.56B
P/E Ratio 23.91x
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
30 /100
Expensive P/B 709.35x
P/E 23.91x
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
21 /100
Poor Asset turnover 0.00x
ROIC 114.16%
ROA 2,417.83%
Debt
100 /100
Low Current ratio 5.31x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
4 /100
Unstable Profitable years 1
Beta 2.61x
EPS volatility 273.83%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. Mel Sorensen
Employees
3
Headquarters
Malvern